Clinical Trials in China / NCT07160036
Recruiting
Not applicable
Repeatability of AO-SLO (Mona IIa) Technology and Cone Cell Density of Individuals Use Repeated Low-level Red-light Therapy
NCT07160036 · tracked via the Priya Life Science China tracker
Condition(s) studied
Myopia
Investigational drug(s) / intervention(s)
RLRL(Model RS-200-2A, Eyerising; Suzhou Xuanjia Optoelectronic Technology Co., Ltd., Suzhou, China))
RLRL(Model RS-200-2A, Eyerising; Suzhou Xuanjia Optoelectronic Technology Co., Ltd., Suzhou, China)): use RLRL twice a day
Study summary
To explore the repeatability of AO-SLO (Mona IIa) technology and the difference of cone cell density between individuals who used or not used repeated low-intensity red light treatment
Eligibility
Inclusion Criteria:
* 6 - 55 years old, gender not limited; Obtained informed consent.
Exclusion Criteria:
* Children with obvious strabismus and amblyopia
* With congenital eye disease, such as congenital cataract, congenital retinal disease
* Secondary myopia (such as premature retinopathy or other eye diseases in infants and children caused secondary myopia), or myopia combined with systemic syndrome (such as Marfan syndrome)
* Had internal eye surgery (such as cataract extraction, intraocular lens implantation, anti-glaucoma surgery, etc.)
* Refractive medium opacity (such as corneal disease, crystal opacity, etc.)
* Bnormal intraocular pressure and clinical significance (IOP \<10 mmHg or IOP\>21mmHg or binocular IOP difference ≥5mmHg)
* Fundus chorioretinopathy (except for high myopia fundus degenerative changes) or other intraocular diseases
* Optic nerve damage or congenital optic nerve dysfunction
* Can not be regularly checked
* The adjustment range is less than 8D or obvious near difficulties
* Other reasons researchers think it is not suitable for inclusion in researchers
Primary outcome measure(s)
- The density of cone cells — From enrollment to the end of treatment at 3 weeks
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Tianjin Medical University Eye Hospital | Tianjin | Tianjin Municipality | Recruiting |
More Ruihua Wei trials in China
Other trials for the same condition
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07160036 on ClinicalTrials.gov ↗ ← All trials in China